Shilpa Medicare Ltd announced on Tuesday, February 24, that its material subsidiary, Shilpa Biologicals Pvt. Ltd., has entered into a licensing agreement with SteinCares...
Shilpa Medicare Ltd. shares gained 3% in intraday trade on Friday, February 13, after the company announced entering into a binding agreement with Switzerland-based...
Healthcare chain Rainbow Children’s Medicare Ltd posted a steady December quarter, driven by higher occupancy and steady procedural mix, though margins saw a mild...
Shilpa Medicare Limited's material subsidiary, Shilpa Biologicals, along with partner mAbTree Biologics, has received Orphan Drug Designation from the US Food and Drug Administration...
Rainbow Children’s Medicare Ltd posted its second-quarter results on Thursday, November 13, reporting a 4.6% year-on-year decline in net profit at ₹75 crore for...